GTC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Genes to Cells (2005) 10, 897-906. doi:10.1111/j.1365-2443.2005.00887.x
© 2005 Blackwell Publishing or its licensors

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collart, C.
Right arrow Articles by Verschueren, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collart, C.
Right arrow Articles by Verschueren, K.

Smicl is a novel Smad interacting protein and cleavage and polyadenylation specificity factor associated protein

Clara Collart1, Jacques E. Remacle1, Silvia Barabino2,a, Leo A. van Grunsven1, Luc Nelles1, Ann Schellens1, Tom Van de Putte1, Stefan Pype1,b, Danny Huylebroeck1 and Kristin Verschueren1,*

1 Department of Developmental Biology (VIB-07), Flanders Interuniversity Institute for Biotechnology (VIB), and Laboratory of Molecular Biology (Celgen), University of Leuven, B-3000 Leuven, Belgium
2 Department of Cell Biology, Biozentrum, University of Basel, CH-4056, Switzerland


    Abstract
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
Ligand-bound receptors of the Transforming Growth Factor-ß (TGF-ß) family promote the formation of complexes between Smad proteins that subsequently accumulate in the nucleus and interact there with other transcriptional regulators, leading to modulation of target gene expression. We identified a novel nuclear protein, Smicl, which binds to Smad proteins. Smicl and Smads cooperate and enhance TGF-ß mediated activation of a Smad-responsive reporter gene. A domain with five CCCH-type zinc fingers in Smicl is structurally and functionally, at least in vitro, similar to a domain in CPSF-30, the 30 kDa subunit of Cleavage and Polyadenylation Specificity Factor (CPSF). Like CPSF-30, Smicl can associate with some other CPSF subunits characterized previously. Its effect on the induction of a reporter gene for TGF-ß requires the cleavage/polyadenylation signal downstream of the coding sequence of that gene. Thus, Smicl is a novel protein that displays CPSF-30-like activities, interacts in the nucleus with activated Smads, and potentiates in TGF-ß stimulated cells Smad-dependent transcriptional responses, possibly in conjunction with the activity of CPSF complexes.


    Introduction
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
TGF-ß ligands elicit cellular responses by binding to two types (named type I and II) of transmembrane receptor with serine/threonine kinase activity (reviewed in Massague & Weis-Garcia 1996; ten Dijke et al. 1996). Dimers of type II receptor bind ligands and are proposed to recruit type I receptors (also termed activin receptor-like kinases or ALKs) in the complex, and activate the latter by phosphorylation. These type I receptors transduce the signal to downstream substrates, the Smad proteins. The receptor-regulated Smads (R-Smads) include Smad1, Smad5 and Smad8, which transduce signals for bone morphogenetic proteins (BMPs), whereas Smad2 and Smad3 appear to act downstream of TGF-ßs, nodal and activins. The R-Smads are directly phosphorylated at specific serine residues in their MH2 domain by activated type I receptors. As a common component of different pathways, the common-mediator Smad (co-Smad) Smad4 oligomerizes with R-Smads after their activation and the complexes translocate to the nucleus. Smads participate directly in the regulation of target gene expression through a variety of mechanisms (reviewed in Massague & Wotton 2000) involving the binding to DNA and/or their interaction with transcription factors and coactivators or corepressors.

In a few cases TGF-ß signaling is known to result in the regulation of gene expression at the post-transcriptional level also. This usually occurs through modulation of mRNA turnover. For example, TGF-ß1 stimulates tropoelastin production in adult rat fibroblasts by increasing the stability of its mRNA. This occurs through a reduction of the binding activity of a cytosolic 50 kDa protein to a specific element within the tropoelastin mRNA open reading frame (Zhang et al. 1999). Tropoelastin mRNA levels decrease as the binding activity of the 50 kDa protein increases. TGF-ß1 regulates also the stability of Indian hedgehog (Ihh) (Murakami et al. 1997) and Pax2 mRNAs (Liu et al. 1997) but the precise mechanisms remain to be elucidated. Indeed, post-transcriptional regulation of gene expression by members of the TGF-ß family remains altogether a largely unexplored field.

We report the cloning and characterization of the novel Smad-interacting protein Smicl. It is related to the 30 kDa subunit of the pre-mRNA processing factor Cleavage and Polyadenylation Specificity Factor (CPSF). CPSF is one of the six factors that act together to achieve efficient pre-mRNA processing in vitro. Functional CPSF consists of at least four subunits (160, 100, 73 and 30 kDa, respectively) and participates in both cleavage and polyadenylation of de novo transcripts. Smicl was found to interact with a number of these CPSF subunits. Moreove, Smicl dependent induction of a TGF-ß responsive reporter gene requires the presence of an intact cleavage/polyadenylation signal. Thus, Smicl is a new CPSF interacting protein and component TGF-ß signaling cascades. The described interactions may point to the existence of mechanisms coupling Smad dependent transcription with pre-mRNA processing.


    Results
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
Two-hybrid cloning of a novel polypeptide and analysis of its interaction with Smads

A yeast two-hybrid screening was carried out with the Smad1 MH2 domain as bait and cDNA prepared from mouse E12.5 embryos as source of prey polypeptides (Verschueren et al. 1999). In addition to SIP1, which is a DNA-binding transcriptional repressor (Remacle et al. 1999; Comijn et al. 2001; Tylzanowski et al. 2001), we identified another polypeptide (named th12) of 352 amino acids (aa) in-frame with the GAL4-transactivation domain of the prey plasmid. Cloning and sequencing of the complete open reading frame (950 amino acids) revealed that the th12 polypeptide encompasses aa 2–353 of the full-length protein. Whereas this polypeptide interacted with the mouse Smad2 and Smad5 MH2 domains, it did not interact with a Smad1 MH2 domain from which the last 40 amino acids were removed, suggesting that this part of R-Smads is essential for interaction. In addition, the GST fusion proteins containing the Smad1, Smad2 or Smad5 MH2 domain specifically pulled down th12 from crude HeLa cell extracts (Fig. 1, lanes 6, 2 and 4, respectively), whereas no pull-down was observed with the negative controls (Fig. 1, lanes 7–10 and 1, 3, 5). This confirms the specificity of the th12/Smad interaction.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 1  Interaction of the th12 polypeptide (aa 2–353 of full-length Smicl) with Smad MH2 domains in an in vitro GST pull-down assay. Th12, HA-tagged at its N-terminal end, was produced in HeLa cells with the T7 vaccinia virus (T7 vv) expression system. Smad1, Smad2 and Smad5 MH2 domains were produced in E. coli as fusion proteins with GST (Verschueren et al. 1999). An unrelated GST fusion protein (GST-CD40 (Pype et al. 2000)) and GST itself were used as negative controls (lanes 7–10). The GST-Smad proteins were purified from E. coli extracts by coupling to glutathione beads and these beads were incubated with a total protein extract from HeLa cells producing th12 polypeptide (lanes 2, 4 and 6) or infected with recombinant T7 vv alone (indicated as T7 controls; lanes 1, 3, 5, 7 and 9). Pulled-down products were separated by SDS-PAG electrophoresis and the identity of the bands was confirmed by Western blotting with an anti-HA antibody (upper panel). The amount of GST-fusion proteins used in the interaction test was estimated by Ponceau-S staining of the blot (lower panel).

 
Smicl is a novel protein with homology to CPSF-30

The th12 cDNA encoded a continuous open reading frame that lacked a translation start or stop codon. However, it displayed a high degree of sequence identity over a region of 1000 nucleotides with (the partial) human KIAA0150 cDNA. Based on this and other sequence homologies found in the EST database, standard PCR techniques were used to obtain a full-length cDNA encoding a protein of 950 amino acids (accession number AJ516034). A striking feature of this protein is the presence of a zinc finger cluster containing five fingers of the CCCH-type (Fig. 2A), which is a motif found in the RNA-binding protein CPSF-30 (accession number AF033201; Fig. 2B). Consequently, the novel protein was named Smad-interacting CPSF-like factor (Smicl).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 2  (A) Schematic representation of the domain structure of the full-length Smicl protein and the th12 polypeptide isolated in the yeast two-hybrid screening. Numbering refers to amino acids in the full-length protein. SBD: Smad Binding Domain; the ellipses represent the five CCCH-type zinc fingers. (B) Alignment of the 5xCCCH zinc finger domain (from amino acid 669–792 for Smicl) of mouse CPSF-30 and Smicl; gray shaded residues are conserved and include the cysteine residues of the zinc fingers.

 
Smicl interacts with activated R-Smads and Smad4 in mammalian cells

To investigate the function of Smicl in TGF-ß signaling, we first documented the interaction between Smicl and Smads in mammalian cells. A plasmid encoding Myc-tagged Smicl (MycSmicl) was co-transfected with plasmids encoding Flag-tagged Smad1, Smad3 or Smad4 proteins, with or without constitutively active (ca) ALK6 (a type I BMP receptor known to activate Smad1 (Hoodless et al. 1996; Kretzschmar et al. 1997)) or caALK4 (for obtaining Smad3 activation (Nakao et al. 1997)). Smad proteins were immunoprecipitated with an anti-Flag antibody and the precipitates were analyzed by Western blotting using anti-Myc antibody. Weak binding of transfected Smad1 or Smad3 to Smicl was detectable in non-stimulated cells (Fig. 3A, lanes 5 and 3, respectively) but this binding increased strongly upon co-transfection of the active variant of the respective type I receptors (Fig. 3A, lanes 4 and 2). The binding of Smicl to Smad4 was also stimulated by activation of the Smad signal transduction pathway (Fig. 3A, lanes 6 and 7). The same results were obtained when Smicl was precipitated first, followed by detection of the Smad proteins (data not shown).



View larger version (50K):
[in this window]
[in a new window]
 
Figure 3  Physical interaction of Smicl with Smads and its subcellular localization. (A) HEK293T cells were transfected with combinations of expression plasmids for Myc-tagged Smicl, Flag-tagged Smad1, Smad3 or Smad4, and HA-tagged caALK6 or caALK4, as indicated. Immunoprecipitation (IP) of proteins from the cell lysates was done with anti-Flag antibody, and the precipitates were analyzed with anti-Myc antibody after Western blotting (W). (B) Nuclear localization of endogenous Smicl in HeLa cells, analyzed by indirect immunofluorescence using polyclonal affinity-purified anti-Smicl anti-peptide antibodies. The antibody is specific for Smicl, as Western blot analysis of HeLa cell extracts reveals a single protein of expected size.

 
In COS cells transfected with a construct that drives over-expression of His-tagged Smicl, the protein was found predominantly in the nucleus. This localization was independent of the activation of the signal transduction cascade (data not shown). Endogenous Smicl protein, detected with an antiserum raised against two Smicl peptides, was also localized to the nucleus, in both stimulated and non-stimulated HeLa cells (Fig. 3B). R-Smads and Smad4 have been shown to accumulate in the nucleus after stimulation. Thus, Smads and Smicl can co-localize in this compartment, which may explain the significantly enhanced complex formation after activation of the signal transduction cascade.

Smicl potentiates ALK4 induced Smad dependent transcriptional responses

R-Smads and Smad4 bind to DNA and activate transcription after stimulation of cells with TGF-ß/activins or BMPs (Massague & Wotton 2000). Accordingly, transcription of a synthetic reporter gene, containing in its regulatory region four copies of a Smad-binding sequence (4xSBE), derived from the JunB promoter, was induced upon co-expression of caALK4 or caALK6, as was reported before (Jonk et al. 1998) (Fig. 4A,B). Importantly, co-expression of Smicl enhanced the caALK4 mediated induction significantly (Fig. 4A), whereas the transcriptional response induced by caALK6 was not affected by Smicl (Fig. 4B). From the latter, we can conclude that although activated Smad1, acting downstream of ALK6 was found to bind Smicl in co-immunoprecipitation assays, this interaction appears to be non-functional, at least in the conditions tested.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 4  Enhancement of (A) caALK4- but not (B) caALK6-induced 4xSBE reporter activity by Smicl in HEK293T cells. Luciferase activity of a 4xSBE reporter (4xSBE) and a modified 4xSBE reporter with mutations in each of the 4 SBEs (SBEmut; (Jonk et al. 1998)), was measured in cells with and without co-transfected caALK4 or caALK6. Smicl and Smicl{Delta}SBD were used here. The results are presented as x-fold induction relative to the basal activity of the reporter (i.e. in the absence of any co-transfected expression plasmid). pCMV-ßgal plasmid was co-transfected for normalization.

 
To further verify whether the activity of Smicl on caALK4 induced reporter activity is mediated through interaction with Smads, a Smicl mutant protein that lacks the Smad Binding Domain (Smicl{Delta}SBD), which was mapped by a yeast two-hybrid assay to amino acids 35–89 (data not shown) was generated. This mutant variant did not detectably interact with R-Smads in a co-immunoprecipitation (co-ip)/Western analysis (see Fig. 6C). Nevertheless, Smicl{Delta}SBD was produced at levels comparable to wild-type Smicl and, similar to the latter, was present in the nucleus (data not shown). This mutant Smicl protein was much less potent than wild-type Smicl in enhancing the caALK4 mediated induction of reporter activity, although a residual activity was still seen (Fig. 4A). This residual activity could be due to remaining interaction with Smads below the detection limit of our co-ip/Western assay. Alternatively, there might be some residual indirect interaction via other proteins, since Smads and Smicl may be part of bigger complexes.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 6  Interaction of Smicl with endogenous CPSF subunits. (A) Interaction of endogenous Smicl with endogenous CPSF-73 in HEK293T cells. Smicl was immunoprecipitated from HEK293T cell extracts using the anti-peptide anti-Smicl antibody and the immunoprecipitates analyzed for the presence of CPSF-73 by immunoblotting using an anti-CPSF-73 antiserum (lane 1). (B) Interaction of MycSmicl with endogenous CPSF-100 or Smad2/3, and exclusion of Smad2/3 from a MycSmicl-CPSF100 complex. Hek293T cells were transiently transfected with a vector encoding Myc-tagged Smicl. Immunoprecipitation (IP) from the cell extract was performed with a monoclonal anti-CPSF100 antibody (IP: {alpha}100) and controlled in Western blots (W) with a polyclonal anti-CPSF100 antiserum (lane 1). Co-immunoprecipitation of MycSmicl or endogenous Smad2/3 was investigated by immunoblotting of the precipitate with anti-Myc (lane 1) or polyclonal anti-Smad2/3 antibodies (lane 3). To analyze binding of endogenous Smad2/3 with Myc-tagged Smicl, anti-Myc immunoprecipitates were analyzed for the presence of these proteins by immunoblotting using the polyclonal anti Smad2/3 antibodies (lane 4). Lanes 2 of Fig. 6A and 6B (no Ab) confirm that there was no aspecific binding of CPSF-73, CPSF-100 or Smicl to the protein G beads in these experiments. (C) Interaction of mutant Smicl protein lacking the SBD with endogenous CPSF-100. A plasmid encoding MycSmicl without SBD (MycSmicl{Delta}SBD) was transfected in HEK293T cells. Immunoprecipitation of endogenous CPSF-100 was followed by immunoblotting using anti-Myc antibody for detection of MycSmicl{Delta}SBD, which was still present in the precipitate (lane 1). The same Smicl mutant protein did not interact with Flag-Smad3. In the latter experiment, the cells were transfected with plasmids encoding Flag-Smad3 and MycSmicl{Delta}SBD. After immunoprecipitation with a monoclonal anti-Flag antibody, the precipitate was analyzed for presence of MycSmicl{Delta}SBD by immunoblotting using anti-Myc antibody (lane 2).

 
Last but not least, a reporter gene with mutated SBE sequences was used (4xSBEmut) such that Smad binding is abolished (Jonk et al. 1998). In this case, the enhancing effect of Smicl was not seen (Fig. 4A). Thus, Smicl does not seem to affect the basal promoter activity in this assay. Rather, binding of Smad2/3 and Smad4 to the DNA is required for the Smicl-induced potentiation. In conclusion, our data indicate that Smicl enhances the caALK4-induced response of the 4xSBE reporter significantly through a mechanism involving binding of Smad2/3 and 4 to the DNA and interaction of Smicl with these Smads.

Sequence similarity and features of the Smicl 5xCCCH domain

Smicl contains five zinc fingers in its C-terminal portion (Fig. 2A), and a similar 5xCCCH domain was found in the C-terminal part of mammalian CPSF-30 (accession numbers AF033201 and BTU96448) and in CPSF-30 homologs such as Drosophila clipper (Bai & Tolias 1996, 1998). CPSF-30 is an RNA-binding protein required for cleavage and polyadenylation of pre-mRNA (Barabino et al. 1997, 2000). The zinc finger domain of clipper has been shown to bind in a nonspecific manner to single-stranded DNA (ssDNA) but not to double-stranded (ds) DNA, and to possess ribonuclease (RNase) activity (Bai & Tolias 1996). Hence, we investigated whether the 5xCCCH domain of Smicl (amino acids 634–803 produced as a GST fusion protein) binds to ssDNA and degrades the same RNA substrate as the clipper zinc fingers. A gel retardation assay was carried out with single-stranded kappa immunoglobulin heavy chain enhancer oligonucleotide ({kappa}E2; Sekido et al. 1994) as a probe. As a control, the same oligonucleotide, but now in its double-stranded form, was used. The Smicl 5xCCCH domain was found to bind ssDNA but not dsDNA (Fig. 5A). As expected, the C-terminal zinc finger cluster of SIP1, previously shown to bind to the {kappa}E2 probe (Verschueren et al. 1999), bound strongly to the dsDNA probe but not to the ssDNA probe.



View larger version (67K):
[in this window]
[in a new window]
 
Figure 5  (A) In vitro binding of the Smicl 5xCCCH domain to single-stranded DNA. A gel retardation assay using the {kappa}E2 probe (Sekido et al. 1994) as double-stranded (ds) and single-stranded (ss) DNA probe, respectively, and the Smicl 5xCCCH domain (lanes 1–2) and SIP1CZF (lanes 3–4) as nucleic acid-binding polypeptides. The arrows denote the shifted probe. (B) In vitro RNAse activity of the Smicl zinc finger domain. GST-fusion proteins of Smicl5xCCCH, the negative control proteins CD40 (i.e. its cytoplasmic tail; (Pype et al. 2000)), th1 (a DNA-binding fragment of the transcriptional repressor SIP1; (Verschueren et al. 1999)) and PLAG (an unrelated zinc finger protein; (Kas et al. 1998)), and the N-terminal part of Smicl (i.e. th12), were produced in E. coli and purified. A radiolabelled RNA substrate (Bai & Tolias 1996) was produced by in vitro transcription and incubated with the GST-fusion proteins. Equal aliquots of each reaction were removed at the indicated time (T) points and analyzed by electrophoresis, followed by autoradiography. Smicl 5xCCCH degraded the RNA substrate (lanes 1–5). The substrate was not visibly degraded after 60 min in a control cleavage reaction without any Smicl added (lane 6). The negative control proteins PLAG, CD40, th1 (see text) and th12 (see text) do not have RNase activity.

 
To investigate the potential RNase activity of the Smicl 5xCCCH domain, we used an in vitro degradation assay with a radio-labeled RNA substrate identical to the one used for clipper (Bai & Tolias 1996). The GST-5xCCCH fusion protein was incubated with the RNA substrate and degradation analyzed by electrophoresis followed by autoradiography. The 5xCCCH domain of Smicl (but none of the other tested GST fusion proteins) effectively degraded the substrate (Fig. 5B).

Smicl binds to CPSF subunits and Smad proteins affect binding of CPSF-100 to Smicl

The nuclear localization of Smicl, and the structural and functional similarities of its zinc finger domain with CPSF-30, suggested a possible association of Smicl with CPSF subunits. This was confirmed by co-immunoprecipitation experiments. Immunoprecipitates of endogenous Smicl were found to contain at least one of the endogenous CPSF subunits: CPSF 73 (Fig. 6A). This prompted us to verify whether Smads could be part of a Smicl-containing CPSF complex. Myc-tagged Smicl could be co-immunoprecipitated with endogenous CPSF-100 in these experiments (Fig. 6B, lane 1), but we could not detect endogenous Smad2 or Smad3 in this immunoprecipitate (Fig. 6B, lane 3). In contrast, endogenous Smad2/3 was found to interact with Myc-tagged Smicl (Fig. 6B, lane 4), even without co-transfection of an expression construct encoding caALK4. Most likely, this is due to the presence of a basal level of TGF-ß signaling in HEK293T cells, as seen by the presence of phosphorylated Smad2 without exogenous TGF-ß stimulation (data not shown and Verschueren et al. 1999).

In conclusion, it appeared that Smicl and Smads do not bind simultaneously to CPSF-100. We then asked whether this mutually exclusive binding could be due to competition of Smads and CPSF-100 for a common binding site in Smicl. Deletion of the Smad binding domain abolished interaction of Smicl with Smad3, but not with the 100 kDa subunit, indicating that the proteins interact through separate domains in Smicl (Fig. 6C). Thus, mutually exclusive interaction could occur by binding of one protein inhibiting the binding of the other.

The presence of a cleavage/polyadenylation signal on pre-mRNA is required for Smicl to potentiate caALK4-mediated induction of reporter activity

The observations that the Smicl 5xCCCH domain binds to ssDNA and has RNase activity, and that Smicl associates with CPSF subunits, raised the question of whether Smicl affects 3'-end processing of target pre-mRNAs. We therefore studied the requirement of the poly(A) signal for Smicl-dependent potentiation of TGF-ß/Smad reporter gene activity. To verify the involvement of this cis-acting sequence, we used the 3TP-Lux reporter plasmid, which can be linearized upstream of its SV40 early poly(A) signal. Such an approach leaves the luciferase sequence intact but should lead to premature termination of the transcript by a run-off event, as no other 3'-end processing signal is present in cis. This strategy was used rather than deletion of the sequence in the plasmid because this would yield transcriptional read-through resulting in no luciferase activity.

As observed in experiments using the 4xSBE reporter, Smicl potentiated the response of this reporter to caALK4 in CHO cells. Moreover, the activity of the linearized reporter was substantially lower than the activity of the circular reporter, but the relative induction by caALK4 occurred to the same extent for the linearized reporter compared to the intact one. However, co-transfection of Smicl could no longer potentiate the response of the linearized reporter (Fig. 7A). In contrast, a reporter that was linearized downstream of the polyadenylation signal was still responsive to Smicl (Fig. 7B). We conclude that the Smicl activity in this assay requires the presence of the intact (i.e. not cut away from the preceding coding sequence) 3'-end processing sequence. Moreover, a Smicl polypeptide (th12) lacking the zinc finger domain did not potentiate induction of the reporter, in contrast to full-length Smicl. Thus, the domain with CPSF30-like activity is also required for Smicl's activity in this assay, further suggesting a role for Smicl in 3'-end formation. Altogether, our data suggest a novel mechanism of Smad-dependent regulation of gene expression, possibly in conjunction with CPSF complexes.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 7  Requirement of an intact cleavage and polyadenylation signal on pre-mRNA for Smicl to potentiate caALK4-mediated induction of reporter activity. The results are presented as x-fold induction relative to the basal activity of the reporter (i.e. in the absence of any co-transfected expression plasmid). Smicl potentiates caALK4-dependent activation of the 3TP-luciferase (3TP-Lux) reporter construct in CHO cells. (A) Induction of this intact reporter, one that was linearized upstream of the cleavage and poly(A) signal and (B) one that was linearized downstream of the cleavage and poly(A) signal, respectively, was investigated in the presence and absence of caALK4. In both panels, pCMV-ßgal plasmid was co-transfected for normalization. Relative induction values (with respect to the basal level of 3TP-luciferase) are shown.

 

    Discussion
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
We report the identification of Smicl, a 950 amino acid-long zinc finger protein, which can associate with members of the Smad family. In mammalian cells, the interaction of full-length Smicl with full-length Smad1, Smad3 and Smad4 is significantly enhanced by receptor-mediated activation. It is known that the stimulation of the signal transduction cascade results in phosphorylation of R-Smads and that these form heteromeric complexes with Smad4, whereupon the heteromeric Smad complexes translocate to the nucleus where they are able to interact with Smad partners, including Smicl. By means of its interaction with Smad2/3, Smicl potentiates the caALK4 dependent transcriptional response of a 4xSBE reporter gene, whereas it does not seem to affect the activity of Smad1 on the same reporter. Thus, even though a complex between Smicl and activated Smad1 was detected, this interaction appeared to be non-functional. This observation may indicate that the interaction itself is not sufficient for the Smicl/Smad complexes to potentiate gene expression and could imply the requirement for at least one additional factor in the complex to obtain this activity.

Smicl contains a 5xCCCH domain in its C-terminal portion. A similar domain is present in CPSF-30. CPSF-30 is a CPSF subunit that together with CPSF-73, -100 and -160 is involved in cleavage and polyadenylation of pre-mRNA. CPSF-30 is a nuclear protein in mammalian somatic cells (Jenny et al. 1994). It can be cross-linked to an AAUAAA-containing RNA substrate (Jenny et al. 1994). The requirement for CPSF-30 in pre-mRNA cleavage and polyadenylation has been demonstrated in vitro, and the second zinc finger is required for this in vitro activity (Barabino et al. 1997, 2000). In addition, the 5xCCCH domain can bind to ssDNA and displays an RNase activity. Together, these data suggest that the activity of the zinc finger cluster in CPSF-30 is important for CPSF mediated cleavage and polyadenylation.

We have found that the 5xCCCH domain of Smicl possesses a similar activity to the zinc finger domain of CPSF-30 inasmuch as it can bind to ssDNA and cleave RNA. In accordance with this, Smicl was found here in a complex with at least two subunits of CPSF, i.e. CPSF-100 and CPSF-73. Thus, Smicl could be part of the 3' pre-mRNA processing machinery. Interaction of Smicl with activated Smad3 or CPSF subunits occurs through distinct domains but nevertheless is mutually exclusive. Smicl might thus be a bifunctional protein that can associate with CPSF subunits on the one hand or engage in a complex with activated and nuclear Smads increasing TGF-ß induced transcriptional responses on the other hand. Importantly, however, the activity of Smicl on potentiation of TGF-ß induced expression of the 3-TPLux reporter required the presence of a cleavage and polyadenylation sequence in cis. How can this observation be reconciled with the mutually exclusive binding of Smicl to either activated Smad3 or CPSF subunits? The answer could come from the fact that transcriptional initiation and 3'-end processing are mechanistically coupled processes. It was shown that CPSF is recruited to the transcription initiation site by TFIID, translocates to the elongation complex and is then transferred to the cleavage/polyadenylation sequence of pre-mRNA (Minvielle-Sebastia & Keller 1999). Similarly, Smicl could be recruited to the promoter of specific genes by transcription factors (such as Smad proteins) and then translocate to the CPSF complex to participate in 3'-end processing, leading to increased gene expression (Fig. 8).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 8  Hypothetical model for Smicl function. In the hypothetical model shown here, Smicl is recruited to the promoter of specific genes by Smad proteins during the transcription initiation process in TGF-ß stimulated cells. Subsequently, Smicl may translocate to the CPSF complex and participate in mRNA 3'-end processing. Abbreviations: PolII A: unphosphorylated form of polymerase II; PolII O: phosphorylated form; CTD: Carboxyl-terminal domain of polymerase II; CTD—P: phosphorylated CTD; CstF: cleavage stimulation factors; SRs: splicing factors (Minvielle-Sebastia & Keller 1999).

 
Alltogether, we suggest that TGF-ß signaling regulates expression of a selective set of genes through coordination between Smad-mediated initiation of transcription and Smicl-driven CPSF-dependent mRNA 3'-end processing. The recruitment of Smicl to Smad-bound promoters by Smads could lead to an enhanced efficiency of the latter process, ensuring a robust increase of specific gene expression. Our results open the way for future studies addressing the role of Smicl interacting CPSF components in either TGF-ß dependent regulation of gene expression by gain- and loss-of-function studies in mammalian cells or in well known TGF-ß regulated processes during embryonic development, using model organisms such as Xenopus.


    Experimental procedures
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
Cell lines and transfections

Cells (HEK293T, COS1 and HeLa) were grown in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (FBS) supplemented with 4.5 g glucose/L for HEK293T cells. Chinese Hamster Ovary (CHO) cells were grown in Ham's F12 with 10% FBS. Cells were transfected using Fugene (Roche Molecular Biochemicals) according to the manufacturer's protocol.

Yeast two-hybrid cloning and assays

For cloning of bait cDNA (for Smads) in pGBT9 and prey cDNAs in pAct2 (Matchmaker I and II, Clontech) see Verschueren et al. (1999). Yeast transformations (strain CG-1945) were performed according to Gietz et al. (1992).

GST-pull down assay

Th12, HA-tagged at its N-terminal end, was produced in HeLa cells with the T7 vaccinia virus (T7 vv) expression system as described in Wuytens et al. (1999). Smad1, Smad2 and Smad5 MH2 domains were produced in E. coli as fusion proteins with GST and used to pull-down th12 polypeptide from cell extracts as described in Verschueren et al. (1999).

Identification of the full-length Smicl cDNA sequence

The full-length mouse Smicl cDNA sequence was obtained by a combination of PCR and 5' RACE (5' RACE kit; Life Technologies) according to the manufacturer's protocol.

Co-immunoprecipitation experiments

cDNAs encoding Smicl or Smicl lacking the SBD (Smicl{Delta}SBD) were subcloned in pCS3 (Rupp et al. 1994) resulting in an N-terminal fusion with the (Myc)6 tag. For construction of Flag-tagged Smads and caALK receptors, see Verschueren et al. (1999). Polyclonal anti-peptide antiserum was raised in rabbits against a mixture of two Smicl peptides (QAPRSPRTKDSGKPL and KAPPGTPRWRNKGYR). Extracts of HEK293T cells were subjected to immunoprecipitations as described in Verschueren et al. (1999). Endogenous CPSF-100, CPSF-73 and Smicl were visualized using anti-CPSF100 (Jenny et al. 1994), anti-CPSF73 (Jenny et al. 1996) and the anti-Smicl polyclonal antisera in combination with HRP-conjugated anti-rabbit antibody (Jackson). Endogenous Smad 2/3 was visualized using anti-Smad 2/3 ((N-19) X; Santa Cruz Biotechnology) and HRP-conjugated anti-goat antibody (Jackson) and the enhanced chemiluminiscence kit (New England Nuclear).

Immunofluorescence

Indirect immunofluorescence was done in transfected COS cells grown on chamber slides, about 24 h after their transfection according to Meersseman et al. (1997). The same protocol was applied for subcellular localization of endogenous Smicl in HeLa cells. Purified Smicl anti-peptide antibody (Eurogentec) and cy2-conjugated goat anti-rabbit IgG were used as primary and secondary antibodies, respectively.

Production of GST fusion proteins

The Smicl 5xCCCH zinc finger domain was obtained as a GST fusion protein by cloning the Smicl cDNA sequence encoding amino acids 634–803 in pGEX-4T-3 (Amersham Pharmacia Biotech). GST fusion proteins of Smicl and of CD40 (Pype et al. 2000), PLAG (Kas et al. 1998), th1 and SIP1CZF (Verschueren et al. 1999) were expressed in E. coli strain BL21. Bacterial cultures were lyzed in BPER reagent (Sigma) and proteins were purified on glutathione-Sepharose beads (Amersham Pharmacia Biotech). Proteins were eluted from the beads with GST elution buffer, containing 0.5 mM ZnSO4, and glycerol was added to a final concentration of 10% for storage at –80 °C. Protein concentrations were estimated on Coomassie Brilliant Blue-stained SDS-polyacrylamide gels (PAG).

Electrophoretic mobility assay

The {kappa}E2 (Sekido et al. 1994) oligonucleotides were labeled with [{gamma}32P]-ATP and T4 polynucleotide kinase (New England Biolabs). GST-fusion proteins were prepared from E. coli (see above) and the DNA binding assay was performed as described in Remacle et al. (1999).

Identity and preparation of the RNA probe

Substrate I (Bai & Tolias 1996) was cloned as an EcoRI/HindIII DNA fragment in pGEM3Z (Promega Corp., Madison, WI) downstream from the T7 promoter. A radio-labeled RNA probe was prepared by in vitro transcription using T7 RNA polymerase. DNA was degraded by RNase-free DNase, and the probe was purified on a Bio-Spin 30 chromatography column (Biorad).

RNA degradation assay

Cleavage was performed in 50 µL reaction mixtures in binding buffer (10 mM Tris-HCl pH 7.5, 5 mM MgCl2, 7 mM dithiothreitol) and contained ±250 ng labeled RNA and ±90 ng GST-coupled proteins, as well as 2 µL of RNasin (40 U/µL). At different time-points, 10 µL samples were collected and the degradation reaction was stopped by adding it to 10 µL of STOP solution (90% formaldehyde and 0.1% bromophenol blue), immediately frozen, and later separated on a denaturing 12% PAG, 7 M urea.

Reporter assays

For the 4xSBE and 3TP-Lux assays, HEK293T and CHO cells, respectively, were collected 30–48 h after transfection. Transfections were done in triplicate in 24-well plates. Each well was transfected with 450 ng of plasmid DNA, 50 ng of luciferase reporter, 50 ng of CMV promoter-based lacZ reporter, and combinations of 50 ng of c.-receptor constructs (caALK4 or caALK6), and 300 ng of N-terminally (Myc)6-tagged Smicl, Smicl{Delta}SBD cDNA or th12 in pCS3. The total amount of DNA was kept constant by adding empty pGEM vector. Cell extracts were assayed for luciferase activity and ß-galactosidase activity according to the manufacturers’ protocols (Promega (Madison, WI, USA) and Clontech (Palo Alto, CA, USA), respectively). The 3TP-Lux reporter construct was linearized in front of and behind its cleavage and polyadenylation sequence with Pfml I and AccI, respectively, and subsequently purified after agarose gel electrophoresis. The data were normalized by calculating the ratio of the luciferase to ß-galactosidase activities. The average normalized luciferase activity is presented relative to the activity in non-stimulated samples as x-fold activation.


    Acknowledgements
 
The D.H. lab wants to thank Henk Stunnenberg, Iain Mattaj and Walter Keller for discussions at an early stage of this work and to Jim Smith for critically reading the manuscript. This work was supported by VIB, the Fund for Scientific Research-Flanders (G.0105.02), the University of Leuven (BOF/0T/00/41), and a grant from the Belgian Science Policy office (IUAP 5/35). C.C. and L.v.G. were supported during part of this work by a predoctoral fellowship from IWT, and a EU-TMR grant (CT98-0216) and a postdoctoral mandate of the Fund for Scientific Research-Flanders, respectively.


    Footnotes
 
Communicated by: Carl-Hendrik Heldin

Present addresses: aDipartimento di Biotechnologie e Bioscienze, Università di Milano-Bicocca, Piazza della Scienza 2, Milano, Italy; Back

bJanssen Research Foundation, Turnhoutsesteenweg 30, B-2340 Beerse, Belgium. Back

* Correspondence: E-mail: kristin{at}med.kuleuven.ac.be


    References
 Top
 Abstract
 Introduction
 Results
 Discussion
 Experimental procedures
 References
 
Bai, C. & Tolias, P.P. (1996) Cleavage of RNA hairpins mediated by a developmentally regulated CCCH zinc finger protein. Mol. Cell. Biol. 16, 6661–6667.[Abstract]

Bai, C. & Tolias, P.P. (1998) Drosophila clipper/CPSF 30K is a post-transcriptionally regulated nuclear protein that binds RNA containing GC clusters. Nucleic Acids Res. 26, 1597–1604.[Abstract/Free Full Text]

Barabino, S.M., Hubner, W., Jenny, A., Minvielle-Sebastia, L. & Keller, W. (1997) The 30-kDa subunit of mammalian cleavage and polyadenylation specificity factor and its yeast homolog are RNA-binding zinc finger proteins. Genes Dev. 11, 1703–1716.[Abstract/Free Full Text]

Barabino, S.M., Ohnacker, M. & Keller, W. (2000) Distinct roles of two Yth1p domains in 3'-end cleavage and polyadenylation of yeast pre-mRNAs. EMBO J. 19, 3778–3787.[CrossRef][Medline]

Comijn, J., Berx, G., Vermassen, P., et al. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7, 1267–1278.[CrossRef][Medline]

ten Dijke, P., Miyazono, K. & Heldin, C.H. (1996) Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr. Opin. Cell Biol. 8, 139–145.[CrossRef][Medline]

Gietz, D., St Jean, A., Woods, R.A. & Schiestl, R.H. (1992) Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 20, 1425.[Free Full Text]

Hoodless, P.A., Haerry, T., Abdollah, S., et al. (1996) MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489–500.[CrossRef][Medline]

Jenny, A., Hauri, H.P. & Keller, W. (1994) Characterization of cleavage and polyadenylation specificity factor and cloning of its 100-kilodalton subunit. Mol. Cell. Biol. 14, 8183–8190.[Abstract/Free Full Text]

Jenny, A., Minnevielle-Sebastia, L., Preker, P. & Keller, W. (1996) Sequence similarity between the 73 kDa protein of mammalian CPSF and a subunit of yeast polyadenylation Factor I. Science 274, 1514–1517.[Abstract/Free Full Text]

Jonk, L.J., Itoh, S., Heldin, C.H., ten Dijke, P. & Kruijer, W. (1998) Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273, 21145–21152.[Abstract/Free Full Text]

Kas, K., Voz, M.L., Hensen, K., Meyen, E. & Van de Ven, W.J. (1998) Transcriptional activation capacity of the novel PLAG family of zinc finger proteins. J. Biol. Chem. 273, 23026–23032.[Abstract/Free Full Text]

Kretzschmar, M., Liu, F., Hata, A., Doody, J. & Massague, J. (1997) The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 11, 984–995.[Abstract/Free Full Text]

Liu, S., Cieslinski, D.A., Funke, A.J. & Humes, H.D. (1997) Transforming growth factor-beta 1 regulates the expression of Pax-2, a developmental control gene, in renal tubule cells. Exp. Nephrol. 5, 295–300.[Medline]

Massague, J. & Weis-Garcia, F. (1996) Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cancer Surv. 27, 41–64.[Medline]

Massague, J. & Wotton, D. (2000) Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19, 1745–1754.[CrossRef][Medline]

Meersseman, G., Verschueren, K., Nelles, L., et al. (1997) The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation. Mech. Dev. 61, 127–140.[CrossRef][Medline]

Minvielle-Sebastia, L. & Keller, W. (1999) mRNA polyadenylation and its coupling to other RNA processing reactions and to transcription. Curr. Opin. Cell Biol. 11, 352–357.[CrossRef][Medline]

Murakami, S., Nifuji, A. & Noda, M. (1997) Expression of Indian hedgehog in osteoblasts and its posttranscriptional regulation by transforming growth factor-beta. Endocrinology 138, 1972–1978.[Abstract/Free Full Text]

Nakao, A., Imamura, T., Souchelnytskyi, S., et al. (1997) TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353–5362.[CrossRef][Medline]

Pype, S., Declercq, W., Ibrahimi, A., et al. (2000) TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. J. Biol. Chem. 275, 18586–18593.[Abstract/Free Full Text]

Remacle, J.E., Kraft, H., Lerchner, W., et al. (1999) New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J. 18, 5073–5084.[CrossRef][Medline]

Rupp, R.A., Snider, L. & Weintraub, H. (1994) Xenopus embryos regulate the nuclear localization of XMyoD. Genes Dev. 8, 1311–1323.[Abstract/Free Full Text]

Sekido, R., Murai, K., Funahashi, J., et al. (1994) The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation. Mol. Cell. Biol. 14, 5692–5700.[Abstract/Free Full Text]

Tylzanowski, P., Verschueren, K., Huylebroeck, D. & Luyten, F.P. (2001) Smad-interacting protein 1 is a repressor of liver/bone/kidney alkaline phosphatase transcription in bone morphogenetic protein-induced osteogenic differentiation of C2C12 cells. J. Biol. Chem. 276, 40001–40007.[Abstract/Free Full Text]

Verschueren, K., Remacle, J.E., Collart, C., et al. (1999) SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes. J. Biol. Chem. 274, 20489–20498.[Abstract/Free Full Text]

Wuytens, G., Verschueren, K., de Winter, J.P., et al. (1999) Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptors. J. Biol. Chem. 274, 9821–9827.[Abstract/Free Full Text]

Zhang, M., Pierce, R.A., Wachi, H., Mecham, R.P. & Parks, W.C. (1999) An open reading frame element mediates posttranscriptional regulation of tropoelastin and responsiveness to transforming growth factor beta1. Mol. Cell. Biol. 19, 7314–7326.[Abstract/Free Full Text]

Received: 25 February 2005
Accepted: 13 June 2005




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
H. Peeters, M. L. Voz, K. Verschueren, B. De Cat, H. Pendeville, B. Thienpont, A. Schellens, J. W. Belmont, G. David, W. J.M. Van De Ven, et al.
Sesn1 is a novel gene for left-right asymmetry and mediating nodal signaling
Hum. Mol. Genet., November 15, 2006; 15(22): 3369 - 3377.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
C. Collart, K. Verschueren, A. Rana, J. C. Smith, and D. Huylebroeck
The novel Smad-interacting protein Smicl regulates Chordin expression in the Xenopus embryo
Development, October 15, 2005; 132(20): 4575 - 4586.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collart, C.
Right arrow Articles by Verschueren, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collart, C.
Right arrow Articles by Verschueren, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS